Table of Contents

company-logo

Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.

Inhibrx Dividend Announcement

• Inhibrx announced a annually dividend of $0.85 per ordinary share which will be made payable on 2024-06-20. Ex dividend date: 2024-05-30
• Inhibrx annual dividend for 2024 was $0.85
• Inhibrx's trailing twelve-month (TTM) dividend yield is 5.31%

Inhibrx Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-05-30$0.85annually2024-06-20

Inhibrx Dividend per year

Inhibrx Dividend Yield

Inhibrx current trailing twelve-month (TTM) dividend yield is 5.31%. Interested in purchasing Inhibrx stock? Use our calculator to estimate your expected dividend yield:

Inhibrx Financial Ratios

P/E ratio0.14
PEG ratio0.00
P/B ratio1.06
ROE1617.60%
Payout ratio0.00%
Current ratio6.20
Quick ratio6.20
Cash Ratio5.81

Inhibrx Dividend FAQ

Does Inhibrx stock pay dividends?
Inhibrx does not currently pay dividends to its shareholders.
Has Inhibrx ever paid a dividend?
No, Inhibrx has no a history of paying dividends to its shareholders. Inhibrx is not known for its dividend payments.
Why doesn't Inhibrx pay dividends?
There are several potential reasons why Inhibrx would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Inhibrx ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Inhibrx has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Inhibrx a dividend aristocrat?
Inhibrx is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Inhibrx a dividend king?
Inhibrx is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Inhibrx a dividend stock?
No, Inhibrx is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Inhibrx stocks?
To buy Inhibrx you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Inhibrx stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.